A citation-based method for searching scientific literature

Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan, Ping Sun, William D Foulkes, Steven A Narod. J Clin Oncol 2004
Times Cited: 414







List of co-cited articles
824 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
27

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
149
27

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
175
25

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
817
24

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Monika K Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G Froster, Bettina Schlehe, Astrid Bechtold, Norbert Arnold,[...]. J Clin Oncol 2009
184
24

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011
115
22

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Todd M Tuttle, Elizabeth B Habermann, Erin H Grund, Todd J Morris, Beth A Virnig. J Clin Oncol 2007
449
19

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
Lori J Pierce, Albert M Levin, Timothy R Rebbeck, Merav A Ben-David, Eitan Friedman, Lawrence J Solin, Eleanor E Harris, David K Gaffney, Bruce G Haffty, Laura A Dawson,[...]. J Clin Oncol 2006
200
19

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
19

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
478
19

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
760
19

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
694
18

Prophylactic mastectomy for the prevention of breast cancer.
Liz Lostumbo, Nora E Carbine, Judi Wallace. Cochrane Database Syst Rev 2010
193
16

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
628
16

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
16

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010
112
16

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Shoshana M Rosenberg, Michaela S Tracy, Meghan E Meyer, Karen Sepucha, Shari Gelber, Judi Hirshfield-Bartek, Susan Troyan, Monica Morrow, Lidia Schapira, Steven E Come,[...]. Ann Intern Med 2013
175
15

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
D Gareth R Evans, Sarah L Ingham, Andrew Baildam, Gary L Ross, Fiona Lalloo, Iain Buchan, Anthony Howell. Breast Cancer Res Treat 2013
89
16

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Bernadette A M Heemskerk-Gerritsen, Matti A Rookus, Cora M Aalfs, Margreet G E M Ausems, Johanna M Collée, Liesbeth Jansen, C Marleen Kets, Kristien B M I Keymeulen, Linetta B Koppert, Hanne E J Meijers-Heijboer,[...]. Int J Cancer 2015
81
18

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
911
14


Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Andrea Eisen, Jan Lubinski, Jan Klijn, Pal Moller, Henry T Lynch, Kenneth Offit, Barbara Weber, Tim Rebbeck, Susan L Neuhausen, Parviz Ghadirian,[...]. J Clin Oncol 2005
300
14

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
Lori J Pierce, Kelly-Anne Phillips, Kent A Griffith, Saundra Buys, David K Gaffney, Meena S Moran, Bruce G Haffty, Merav Ben-David, Bella Kaufman, Judy E Garber,[...]. Breast Cancer Res Treat 2010
100
14

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
C T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, A vd Ouweland, M B E Menke-Pluymers, C C M Bartels, M Kriege, A N van Geel, C W Burger, A M M Eggermont,[...]. Eur J Cancer 2007
143
14

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Lisa J Herrinton, William E Barlow, Onchee Yu, Ann M Geiger, Joann G Elmore, Mary B Barton, Emily L Harris, Sharon Rolnick, Roy Pardee, Gail Husson,[...]. J Clin Oncol 2005
195
14


Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
Tari A King, Rita Sakr, Sujata Patil, Inga Gurevich, Michelle Stempel, Michelle Sampson, Monica Morrow. J Clin Oncol 2011
226
13

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.
Alexandra J van den Broek, Laura J van 't Veer, Maartje J Hooning, Sten Cornelissen, Annegien Broeks, Emiel J Rutgers, Vincent T H B M Smit, Cees J Cornelisse, Mike van Beek, Maryska L Janssen-Heijnen,[...]. J Clin Oncol 2016
51
25

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
S K McDonnell, D J Schaid, J L Myers, C S Grant, J H Donohue, J E Woods, M H Frost, J L Johnson, D L Sitta, J M Slezak,[...]. J Clin Oncol 2001
189
12

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
Hazel B Nichols, Amy Berrington de González, James V Lacey, Philip S Rosenberg, William F Anderson. J Clin Oncol 2011
157
12

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
474
12

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Youlia M Kirova, Alexia Savignoni, Brigitte Sigal-Zafrani, Anne de La Rochefordiere, Rémy J Salmon, Pascale This, Bernard Asselain, Dominique Stoppa-Lyonnet, Alain Fourquet. Breast Cancer Res Treat 2010
60
20

Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.
L J Pierce, M Strawderman, S A Narod, I Oliviotto, A Eisen, L Dawson, D Gaffney, L J Solin, A Nixon, J Garber,[...]. J Clin Oncol 2000
178
12

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.
Bruce G Haffty, Elizabeth Harrold, Atif J Khan, Pradip Pathare, Tanya E Smith, Bruce C Turner, Peter M Glazer, Barbara Ward, Daryl Carter, Ellen Matloff,[...]. Lancet 2002
192
12

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
12

Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
Xiao Li, Ran You, Xinwei Wang, Congxin Liu, Zicheng Xu, Jin Zhou, Bin Yu, Ting Xu, Hongzhou Cai, Qing Zou. Clin Cancer Res 2016
62
19

Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.
Judy C Boughey, Tanya L Hoskin, Amy C Degnim, Thomas A Sellers, Joanne L Johnson, Melanie J Kasner, Lynn C Hartmann, Marlene H Frost. Ann Surg Oncol 2010
90
12

Perceptions of contralateral breast cancer: an overestimation of risk.
Andrea Abbott, Natasha Rueth, Susan Pappas-Varco, Karen Kuntz, Elizabeth Kerr, Todd Tuttle. Ann Surg Oncol 2011
107
11


Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.
E A Peralta, J D Ellenhorn, L D Wagman, A Dagis, J S Andersen, D Z Chu. Am J Surg 2000
146
11

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
Kelly-Anne Phillips, Roger L Milne, Matti A Rookus, Mary B Daly, Antonis C Antoniou, Susan Peock, Debra Frost, Douglas F Easton, Steve Ellis, Michael L Friedlander,[...]. J Clin Oncol 2013
106
11

Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Carlos A Garcia-Etienne, Monica Barile, Oreste D Gentilini, Edoardo Botteri, Nicole Rotmensz, Andrea Sagona, Gabriel Farante, Viviana Galimberti, Alberto Luini, Paolo Veronesi,[...]. Ann Surg Oncol 2009
55
20


Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
Katharine Yao, Andrew K Stewart, David J Winchester, David P Winchester. Ann Surg Oncol 2010
178
10

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
116
10

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.
Anne S Reiner, Esther M John, Jennifer D Brooks, Charles F Lynch, Leslie Bernstein, Lene Mellemkjær, Kathleen E Malone, Julia A Knight, Marinela Capanu, Sharon N Teraoka,[...]. J Clin Oncol 2013
72
13

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Jacek Gronwald, Nadine Tung, William D Foulkes, Kenneth Offit, Ruth Gershoni, Mary Daly, Charmaine Kim-Sing, Hakan Olsson, Peter Ainsworth, Andrea Eisen,[...]. Int J Cancer 2006
176
10

Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Kelly Metcalfe, Henry T Lynch, William D Foulkes, Nadine Tung, Charmaine Kim-Sing, Olufunmilayo I Olopade, Andrea Eisen, Barry Rosen, Carrie Snyder, Shelley Gershman,[...]. JAMA Oncol 2015
60
16

Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
Marlene H Frost, Jeffrey M Slezak, Nho V Tran, Constance I Williams, Joanne L Johnson, John E Woods, Paul M Petty, John H Donohue, Clive S Grant, Jeff A Sloan,[...]. J Clin Oncol 2005
136
9

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
991
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.